These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 10488948)
41. Phospholipid transfer is a prerequisite for PLTP-mediated HDL conversion. Huuskonen J; Olkkonen VM; Ehnholm C; Metso J; Julkunen I; Jauhiainen M Biochemistry; 2000 Dec; 39(51):16092-8. PubMed ID: 11123937 [TBL] [Abstract][Full Text] [Related]
42. The properties of HDL in genetically engineered mice. Schultz JR; Rubin EM Curr Opin Lipidol; 1994 Apr; 5(2):126-37. PubMed ID: 8044415 [TBL] [Abstract][Full Text] [Related]
43. Cholesteryl ester transfer protein promotes the association of HDL apolipoproteins A-I and A-II with LDL: potentiation by oleic acid. Lagrost L; Barter PJ Biochim Biophys Acta; 1992 Aug; 1127(3):255-62. PubMed ID: 1511003 [TBL] [Abstract][Full Text] [Related]
44. The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Huuskonen J; Olkkonen VM; Jauhiainen M; Ehnholm C Atherosclerosis; 2001 Apr; 155(2):269-81. PubMed ID: 11254896 [TBL] [Abstract][Full Text] [Related]
45. Apolipoproteins regulate the kinetics of endothelial lipase-mediated hydrolysis of phospholipids in reconstituted high-density lipoproteins. Caiazza D; Jahangiri A; Rader DJ; Marchadier D; Rye KA Biochemistry; 2004 Sep; 43(37):11898-905. PubMed ID: 15362876 [TBL] [Abstract][Full Text] [Related]
46. The molecular structure of apolipoprotein A-II modulates the capacity of HDL to promote cell cholesterol efflux. Bernini F; Calabresi L; Bonfadini G; Franceschini G Biochim Biophys Acta; 1996 Jan; 1299(1):103-9. PubMed ID: 8555242 [TBL] [Abstract][Full Text] [Related]
47. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux. Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475 [TBL] [Abstract][Full Text] [Related]
48. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641 [TBL] [Abstract][Full Text] [Related]
49. Is reverse cholesterol transport a misnomer for suggesting its role in the prevention of atheroma formation? Quintão EC Atherosclerosis; 1995 Jul; 116(1):1-14. PubMed ID: 7488324 [TBL] [Abstract][Full Text] [Related]
51. Facilitation of phosphatidylcholine transfer into high density lipoproteins by an apolipoprotein in the density 1.20-1.26 g/ml fraction of plasma. Tall AR; Forester LR; Bongiovanni GL J Lipid Res; 1983 Mar; 24(3):277-89. PubMed ID: 6842084 [TBL] [Abstract][Full Text] [Related]
52. [Regulation of serum HDL cholesterol and prevention of atherosclerosis]. Kahri J Duodecim; 2002; 118(18):1863-71. PubMed ID: 12422668 [No Abstract] [Full Text] [Related]
53. Factors influencing interaction of human plasma low-density lipoproteins with discoidal complexes of apolipoprotein A-I and phosphatidylcholine. Shahrokh Z; Nichols AV Biochim Biophys Acta; 1986 Sep; 878(2):152-8. PubMed ID: 3092865 [TBL] [Abstract][Full Text] [Related]
54. Lipases and HDL metabolism. Jin W; Marchadier D; Rader DJ Trends Endocrinol Metab; 2002; 13(4):174-8. PubMed ID: 11943562 [TBL] [Abstract][Full Text] [Related]
55. Role of phospholipid transfer protein in high-density lipoprotein metabolism: insights from studies in transgenic mice. Van Tol A; Jauhiainen M; De Crom R; Ehnholm C Int J Tissue React; 2000; 22(2-3):79-84. PubMed ID: 10937357 [No Abstract] [Full Text] [Related]
56. Molecular and macromolecular specificity of human plasma phospholipid transfer protein. Rao R; Albers JJ; Wolfbauer G; Pownall HJ Biochemistry; 1997 Mar; 36(12):3645-53. PubMed ID: 9132017 [TBL] [Abstract][Full Text] [Related]
57. Interaction between high-density lipoprotein subpopulations in apo B-free and abetalipoproteinemic plasma. Cheung MC; Wolf AC; Illingworth DR Biochim Biophys Acta; 1992 Oct; 1128(2-3):244-9. PubMed ID: 1420297 [TBL] [Abstract][Full Text] [Related]
58. Remodeling of HDL by phospholipid transfer protein: demonstration of particle fusion by 1H NMR spectroscopy. Korhonen A; Jauhiainen M; Ehnholm C; Kovanen PT; Ala-Korpela M Biochem Biophys Res Commun; 1998 Aug; 249(3):910-6. PubMed ID: 9731235 [TBL] [Abstract][Full Text] [Related]
59. ApoA-II versus ApoA-I: two for one is not always a good deal. Castellani LW; Lusis AJ Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1870-2. PubMed ID: 11742857 [No Abstract] [Full Text] [Related]
60. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus. de Vries R; Borggreve SE; Dullaart RP Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]